Mycobacterium tuberculosis Rv3248c Inhibits Type I Interferon Response and Promotes Intracellular Survival by Mediating Ubiquitin-Proteasome-Dependent Degradation of TBK1
{"title":"Mycobacterium tuberculosis Rv3248c Inhibits Type I Interferon Response and Promotes Intracellular Survival by Mediating Ubiquitin-Proteasome-Dependent Degradation of TBK1","authors":"Zhengzhong Xu, Min Geng, Zhifang Zhang, Wanying Wu, Jiaxu Wan, Tian Tian, Chengkun Zheng, Xiang Chen, Xin-an Jiao","doi":"10.1021/acsinfecdis.6c00364","DOIUrl":null,"url":null,"abstract":"<p><em>Mycobacterium tuberculosis</em> (<em>M. tb</em>) is a leading cause of infectious disease\r\nmortality\r\nworldwide, and <em>M. tb</em> subverts host immunity to persist\r\nintracellularly. Type I interferon (IFN-I) modulates host defense\r\nduring <em>M. tb</em> infection, but the mechanisms controlling\r\ntheir induction remain incompletely defined. In this research, a previously\r\nuncharacterized mycobacterial factor, <em>M. tb</em> Rv3248c,\r\nwhich regulates IFN-I response, was identified using pull-down and\r\nmass spectrometry. Overexpression of Rv3248c suppresses IFN-β\r\nexpression in macrophages at both the transcriptional and protein\r\nlevels. In addition, it also enhances intracellular bacterial load,\r\nwhereas in bone marrow-derived macrophages (BMDMs) from Ifnar1<sup>–/–</sup> C57BL/6 mice, the difference of bacterial\r\nload was no longer statistically significant, suggesting that Rv3248c\r\nenhances mycobacterial survival in IFN-I-dependent manner. Furthermore,\r\nthe study shows that <em>M. tb</em> Rv3248c inhibits IFN-I\r\nresponse via the cGAS-STING pathway. Mechanistically, Rv3248c binds\r\nTANK-binding kinase 1 (TBK1) and promotes its ubiquitination-mediated\r\nproteasomal degradation. The N-terminal region of Rv3248c (amino acids\r\n1–134) is required for TBK1 interaction and IFN-I inhibition.\r\nThese findings identify a previously uncharacterized mechanism by\r\nwhich <em>M. tb</em> dampens the IFN-I response by targeting\r\nTBK1, highlighting Rv3248c as a contributor to pathogenesis and a\r\npotential therapeutic target.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 10","pages":"3385–3397"},"PeriodicalIF":4.5000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.6c00364","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/22 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Mycobacterium tuberculosis (M. tb) is a leading cause of infectious disease
mortality
worldwide, and M. tb subverts host immunity to persist
intracellularly. Type I interferon (IFN-I) modulates host defense
during M. tb infection, but the mechanisms controlling
their induction remain incompletely defined. In this research, a previously
uncharacterized mycobacterial factor, M. tb Rv3248c,
which regulates IFN-I response, was identified using pull-down and
mass spectrometry. Overexpression of Rv3248c suppresses IFN-β
expression in macrophages at both the transcriptional and protein
levels. In addition, it also enhances intracellular bacterial load,
whereas in bone marrow-derived macrophages (BMDMs) from Ifnar1–/– C57BL/6 mice, the difference of bacterial
load was no longer statistically significant, suggesting that Rv3248c
enhances mycobacterial survival in IFN-I-dependent manner. Furthermore,
the study shows that M. tb Rv3248c inhibits IFN-I
response via the cGAS-STING pathway. Mechanistically, Rv3248c binds
TANK-binding kinase 1 (TBK1) and promotes its ubiquitination-mediated
proteasomal degradation. The N-terminal region of Rv3248c (amino acids
1–134) is required for TBK1 interaction and IFN-I inhibition.
These findings identify a previously uncharacterized mechanism by
which M. tb dampens the IFN-I response by targeting
TBK1, highlighting Rv3248c as a contributor to pathogenesis and a
potential therapeutic target.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.